[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100395621":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":39,"centralContacts":44,"locations":50,"responsibleParty":175,"collaborators":177,"id":181,"slug":10,"hasResults":182,"nctId":183,"briefTitle":184,"officialTitle":185,"acronym":10,"eligibilityCriteria":186,"healthyVolunteers":182,"sex":187,"minAge":188,"maxAge":10,"enrollmentInfo":189,"targetDuration":10,"studyType":192,"phases":10,"briefSummary":193,"conditions":194,"keywords":10,"overallStatus":66,"whyStopped":10,"lastUpdateSubmitDate":196,"lastUpdatePostDateStruct":197,"startDateStruct":200,"completionDateStruct":202,"leadSponsor":204,"locationsCount":205},{"fullName":5,"class":6},"Fred Hutchinson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (questionnaire, biospecimen, chart review)",null,"Patients complete questionnaires over 10 minutes about physical symptoms, activity level, and emotional well-being and have their medical records reviewed at baseline, 1, 3, and 6 months after starting index treatment, and at start of a new systemic treatment. Patients also undergo collection of blood samples over 1-2 minutes at baseline and at 1 month after starting index treatment, or at a treatment change visit if new therapy has not started.",[13,14,15,16],"Procedure: Biospecimen Collection","Other: Medical Chart Review","Other: Quality-of-Life Assessment","Other: Questionnaire Administration",[18,23,29,35],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"PROCEDURE","Biospecimen Collection","Undergo collection of blood sample",[9],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Medical Chart Review","Review of medical chart",[9],[28],"Chart Review",{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Quality-of-Life Assessment","Ancillary studies",[9],[34],"Quality of Life Assessment",{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":10},"Questionnaire Administration","Complete questionnaire",[9],[40],{"name":41,"affiliation":42,"role":43},"Stephanie J. Lee","Fred Hutch\u002FUniversity of Washington Cancer Consortium","PRINCIPAL_INVESTIGATOR",[45],{"name":46,"role":47,"phone":48,"phoneExt":10,"email":49},"Gaby Desatnik","CONTACT","206-667-1356","cgvhd@fredhutch.org",[51,64,80,96,106,116,132,142,152,164],{"facility":52,"status":53,"city":54,"state":55,"zip":56,"country":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":10},"University of Florida","COMPLETED","Gainesville","Florida","32610","United States",{"type":59,"coordinates":60},"Point",[61,62],-82.32483,29.65163,{"lat":62,"lon":61},{"facility":65,"status":66,"city":67,"state":55,"zip":68,"country":57,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Moffitt Cancer Center","RECRUITING","Tampa","33612",{"type":59,"coordinates":70},[71,72],-82.45843,27.94752,{"lat":72,"lon":71},[75,79],{"name":76,"role":47,"phone":77,"phoneExt":10,"email":78},"Joseph Pidala","888-663-3488","Joseph.Pidala@moffitt.org",{"name":76,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":81,"status":66,"city":82,"state":83,"zip":84,"country":57,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Dana-Farber Harvard Cancer Center","Boston","Massachusetts","02115",{"type":59,"coordinates":86},[87,88],-71.05977,42.35843,{"lat":88,"lon":87},[91,95],{"name":92,"role":47,"phone":93,"phoneExt":10,"email":94},"Corey S. Cutler","617-632-5946","corey_cutler@dfci.harvard.edu",{"name":92,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":97,"status":53,"city":98,"state":99,"zip":100,"country":57,"cosmosGeoPoint":101,"geoPoint":105,"contacts":10},"University of Minnesota\u002FMasonic Cancer Center","Minneapolis","Minnesota","55455",{"type":59,"coordinates":102},[103,104],-93.26384,44.97997,{"lat":104,"lon":103},{"facility":107,"status":53,"city":108,"state":109,"zip":110,"country":57,"cosmosGeoPoint":111,"geoPoint":115,"contacts":10},"Roswell Park Cancer Institute","Buffalo","New York","14263",{"type":59,"coordinates":112},[113,114],-78.87837,42.88645,{"lat":114,"lon":113},{"facility":117,"status":66,"city":118,"state":119,"zip":120,"country":57,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"Cleveland Clinic Foundation","Cleveland","Ohio","44195",{"type":59,"coordinates":122},[123,124],-81.69541,41.4995,{"lat":124,"lon":123},[127,131],{"name":128,"role":47,"phone":129,"phoneExt":10,"email":130},"Betty K. Hamilton","216-444-6833","HAMILTB2@ccf.org",{"name":128,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":133,"status":53,"city":134,"state":135,"zip":136,"country":57,"cosmosGeoPoint":137,"geoPoint":141,"contacts":10},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15232",{"type":59,"coordinates":138},[139,140],-79.99589,40.44062,{"lat":140,"lon":139},{"facility":143,"status":53,"city":144,"state":145,"zip":146,"country":57,"cosmosGeoPoint":147,"geoPoint":151,"contacts":10},"Vanderbilt University\u002FIngram Cancer Center","Nashville","Tennessee","37232",{"type":59,"coordinates":148},[149,150],-86.78444,36.16589,{"lat":150,"lon":149},{"facility":42,"status":66,"city":153,"state":154,"zip":155,"country":57,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"Seattle","Washington","98109",{"type":59,"coordinates":157},[158,159],-122.33207,47.60621,{"lat":159,"lon":158},[162,163],{"name":46,"role":47,"phone":48,"phoneExt":10,"email":49},{"name":41,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":165,"status":53,"city":166,"state":167,"zip":168,"country":169,"cosmosGeoPoint":170,"geoPoint":174,"contacts":10},"Vancouver General Hospital\u002FBC Cancer","Vancouver","British Columbia","V5Z 4E6","Canada",{"type":59,"coordinates":171},[172,173],-123.11934,49.24966,{"lat":173,"lon":172},{"type":176,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[178],{"name":179,"class":180},"National Cancer Institute (NCI)","NIH","100395621",false,"NCT04431479","Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study","Predicting the Quality of Response to Specific Treatments (PQRST)","Inclusion Criteria:\n\n* Adults age 18 or older\n* Prior allogeneic stem cell transplant, with any graft source, donor type, and GVHD prophylaxis\n* No evidence of persistent or progressive malignancy at the time of enrollment\n* Agrees to be evaluated at the transplant center before a new line of treatment is started (may be concurrent with the enrollment visit), and later between 2-6 weeks, 3 months and 6 months after index treatment is started or if an additional new therapy is started before 6 months\n* Signed, informed consent\n\nExclusion Criteria:\n\n* Inability to comply with study procedures\n* Uncontrolled psychiatric disorder\n* Anticipated survival \\\u003C 6 months","ALL","18 Years",{"count":190,"type":191},300,"ESTIMATED","OBSERVATIONAL","This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.",[195],"Chronic Graft Versus Host Disease","2026-05-18",{"date":198,"type":199},"2026-05-20","ACTUAL",{"date":201,"type":199},"2020-06-29",{"date":203,"type":191},"2027-07-01",{"name":5,"class":6},10]